vedolizumab
takeda
[]
largely agree with my friend although i would add vdz to the moderate, no perianal category as it works quite well in this setting. data to be presented at #ecco2023 confirm this in the post op cd setting. 
Gastroenterologist Scientist MD PhD #IBD #Crohnsdisease #colitis #genetics #microbiome #diversity #nutrition. Founder @TorDigHealthIns https://t.co/P3JYSG9yiT